BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lage DP, Ribeiro PAF, Dias DS, Mendonça DVC, Ramos FF, Carvalho LM, Steiner BT, Tavares GSV, Martins VT, Machado AS, Oliveira-da-Silva JA, Santos TTO, Freitas CS, Oliveira JS, Roatt BM, Machado-de-Ávila RA, Humbert MV, Christodoulides M, Coelho EAF. Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis. Vaccines (Basel) 2020;8:E289. [PMID: 32526867 DOI: 10.3390/vaccines8020289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Machado AS, Lage DP, Vale DL, Freitas CS, Linhares FP, Cardoso JMO, Pereira IAG, Ramos FF, Tavares GSV, Ludolf F, Oliveira-da-Silva JA, Bandeira RS, Simões AC, Duarte MC, Oliveira JS, Christodoulides M, Chávez-Fumagalli MA, Roatt BM, Martins VT, Coelho EAF. A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum. Acta Trop 2022;230:106412. [PMID: 35305943 DOI: 10.1016/j.actatropica.2022.106412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Assolini JP, Carloto ACM, Bortoleti BTDS, Gonçalves MD, Tomiotto Pellissier F, Feuser PE, Cordeiro AP, Hermes de Araújo PH, Sayer C, Miranda Sapla MM, Pavanelli WR. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview. Eur J Pharmacol 2022;923:174934. [PMID: 35367420 DOI: 10.1016/j.ejphar.2022.174934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Prasanna P, Kumar P, Kumar S, Rajana VK, Kant V, Prasad SR, Mohan U, Ravichandiran V, Mandal D. Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis - A review. Biomed Pharmacother 2021;141:111920. [PMID: 34328115 DOI: 10.1016/j.biopha.2021.111920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ostolin TLVDP, Gusmão MR, Mathias FAS, Cardoso JMO, Roatt BM, Aguiar-Soares RDO, Ruiz JC, Resende DM, de Brito RCF, Reis AB. A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice. Vaccine 2021;39:2755-63. [PMID: 33875268 DOI: 10.1016/j.vaccine.2021.04.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]